#USA #New York #Class Action #Semler Scientific #Bronstein Gewirtz

Semler Scientific Investors Alert: Join the Class Action Lawsuit

NEW YORK, September 4, 2025 — Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, has announced the initiation of a class action lawsuit on behalf of investors in Semler Scientific, Inc. (NASDAQ: SMLR) who have incurred significant financial losses. This legal move opens up the possibility for affected investors to seek compensation for damages.

Overview of the Class Action Lawsuit

The class action targets all individuals or entities that purchased shares or securities of Semler Scientific during the defined period of March 10, 2021, to April 15, 2025. Investors who qualify and have suffered losses during this time frame are strongly encouraged to participate by visiting the law firm’s dedicated webpage at bgandg.com/SMLR.

Allegations Against Semler Scientific

The complaint rests on allegations that during the class period, Semler Scientific and its officers made materially false statements or omitted critical information regarding potential legal issues facing the company. Key allegations include:
1. The failure to disclose an ongoing investigation by the U.S. Department of Justice concerning violations of the False Claims Act, even while discussing similar issues in hypothetical terms.
2. A subsequent failure to provide accurate public communications led investors to believe the company was in good standing, resulting in inflated stock prices.

When the true circumstances surrounding the company’s legal troubles became public, the value of Semler’s shares significantly dropped, resulting in financial losses for investors. The lawsuit aims to hold those responsible accountable and seek reparations for affected parties.

Next Steps for Interested Investors

A class action lawsuit has already been set in motion, and investors wishing to review the official complaint can access it through the law firm’s site. For additional inquiries, investors can contact Peretz Bronstein or his Client Relations Manager, Nathan Miller, directly at 332-239-2660. Notably, those who experienced financial losses related to Semler Scientific have until October 28, 2025, to request consideration as the lead plaintiff in the case. Importantly, the ability to claim compensation does not necessitate serving as the lead plaintiff.

Free Representation for Investors

Bronstein, Gewirtz & Grossman, LLC affirms that they operate on a contingency fee basis in class action scenarios, meaning that affected investors will not incur any upfront costs. The firm will only seek reimbursement for expenses and attorney fees contingent upon a successful outcome, typically given as a percentage of the total recovery obtained.

Why Choose Bronstein, Gewirtz & Grossman, LLC?

Having established itself as a nationally recognized law firm, Bronstein, Gewirtz & Grossman has been instrumental in representing investors in securities fraud class actions and shareholder derivative lawsuits. The firm boasts a successful track record, having recovered hundreds of millions of dollars for its clients nationwide.

To stay updated, investors can follow the firm on social media platforms, including LinkedIn, Twitter, Facebook, and Instagram. Remember, attorney advertising regulations apply, and the past success of this firm does not guarantee future outcomes.

For further assistance or to get involved in this significant legal action concerning Semler Scientific, interested investors are encouraged to act swiftly. The clock is ticking, and participation could prove pivotal in achieving a favorable resolution.